Tempus AI Announces Initiative To Build Research Platform Containing 100K Whole Genomes Linked To Longitudinal Clinical Information Over Next Several Years
The Initiative Will Make Available 100,000 Disease-Specific Whole Genome Sequences Paired with Longitudinal Clinical Outcomes, with a Long-Term Goal of Reaching 1 Million GenomesTempus AI, Inc. (NASDAQ:TEM) today
Tempus AI is building a huge library of genetic information from 100,000 people to help doctors understand diseases better. This shows the company is investing in a long term plan, which hints at confidence in their business direction.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.